Sonoma Pharmaceuticals (SNOA) Tops Q3 EPS by 6c

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.63), $0.06 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $4 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ishares Msci South Korea Capped Etf (EWY) call put ratio 1 call to 1.5 puts as share price down 9.3%
• Cushman & Wakefield names two capital markets leaders in APAC